Santarus Pages on BioPortfolio:

Santarus Achieves $2.5 Million Regulatory Milestone under OTC ...
Freshnews.com:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Santarus Zegerid - Fast-acting formulation gaining momentum in GERD
Santarus Zegerid - Fast-acting formulation gaining momentum in GERD Following the lackluster 2004 launch of an oral suspension formulation of Santarus' lead
...
http://www.bioportfolio.com/cgi-bin/acatalog/Santarus_Zegeri...

BioPortfolio - Santarus
Santarus - Entry on Bioportfolio's Biocorporate Database. ... Santarus Zegerid - Fast-acting formulation gaining momentum in GERD ...
http://www.bioportfolio.com/search/Santarus.html...

Santarus Achieves $2.5 Million Regulatory Milestone under OTC ...
FinanzNachrichten.de:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - santarus.com
santarus.com - BioPortfolio. ... Santarus Inc. Licenses Rights to GlaxoSmithKline for ZEGERID . ... http://www.bioportfolio.com/search/santarus.
com.html. ...
http://www.bioportfolio.com/search/santarus.com.html...

Santarus Provides Termination Notice to Otsuka America ...
Healthcare Sales & Marketing Network:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Santarus Achieves $2.5 Million Regulatory Milestone under OTC ...
Financial Times via MSN Money:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Santarus pharma contact details
Santarus pharma contact details - BioPortfolio. ... Recent Search Terms used to find this page: santarus | santarus pharma sales force . ...
http://www.bioportfolio.com/search/Santarus_pharma_contact_d...

Results from other life science and pharmaceutical sites:

BioSpace - Santarus Inc. News, Search Jobs, Events
Santarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients ...
http://www.biospace.com/company_profile.aspx?CompanyId=79504...

Santarus Inc. Terminates Co-promotion Agreement with Otsuka ...
Under the co-promotion agreement, Otsuka America has provided promotional support in the U.S. related to Santarus’ ZEGERID® (omeprazole/sodium bicarbonate
) ...
http://www.biospace.com/news_story.aspx?NewsEntityId=92824...

Santarus to promote Depomed diabetes drug: Financial News - Yahoo ...
Santarus to promote Depomed diabetes drug. - SAN DIEGO (AP) -- Santarus Inc. said Tuesday it agreed to promote Depomed Inc.'s diabetes drug Glumetza in the
...
http://biz.yahoo.com/ap/080722/santarus_glumetza.html?.v=1...

Santarus Increases Revolving Line of Credit to $25 Million and ...
Santarus Increases Revolving Line of Credit to $25 Million and Extends Maturity to July 2011. - SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS ...
http://biz.yahoo.com/bw/080714/20080714005115.html?.v=1...

News: Santarus to Present at Two September Investment Conferences ...
Santarus to Present at Two September Investment Conferences. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=40990724...

Live Call: Santarus Inc. and Depomed Announce U.S. Promotion ...
22 Jul 2008 ... Santarus, Inc., a specialty pharmaceutical company, ... Santarus was founded in 1996 and is based in San Diego, California. ...
http://biz.yahoo.com/cc/5/95405.html...

Santarus Inc. Increases Revolving Line of Credit to $25 Million ...
Santarus entered into its first line of credit with Comerica in July 2006 with an original maturity date of July 28, 2009. Santarus will make interest-only ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103200...

Omeprazole/Antacid-powder suspension-Santarus: ome...[Drugs R D ...
Santarus Inc. is developing an immediate-release formulation of omeprazole in ... Santarus have also licensed technology from Tulane and North Carolina ...
http://www.ncbi.nlm.nih.gov/pubmed/15563239...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.